LANDONI FABIO

Ruolo:

Professore associato

Settore scientifico disciplinare:

GINECOLOGIA E OSTETRICIA (MED/40)

Afferenza:

E-mail:

Ceppi, L., Grassi, T., Galli, F., Buda, A., Aletti, G., Lissoni, A., et al. (2021). Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers. GYNECOLOGIC ONCOLOGY, 160(1), 64-70. Dettaglio
Di Martino, G., Lissoni, A., Ferrari, D., Di Meo, M., Cosio, S., Gadducci, A., et al. (2021). Dose-dense neoadjuvant chemotherapy with paclitaxel and carboplatin in cervical cancer: Efficacy on pathological response. ANTICANCER RESEARCH, 41(1), 497-502. Dettaglio
Conconi, D., Redaelli, S., Lissoni, A., Cilibrasi, C., Perego, P., Gautiero, E., et al. (2021). Genomic and epigenomic profile of uterine smooth muscle tumors of uncertain malignant potential (Stumps) revealed similarities and differences with leiomyomas and leiomyosarcomas. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22(4), 1-16. Dettaglio
Bogani, G., Papadia, A., Buda, A., Casarin, J., Di Donato, V., Gasparri, M., et al. (2021). Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional study. GYNECOLOGIC ONCOLOGY, 161(1 (April 2021)), 122-129. Dettaglio
Gadducci, A., Cosio, S., Lissoni, A., Zizioli, V., Adorni, M., Ferrero, A., et al. (2020). Imact of bevacizumab-containing primary treatment on outcome of recurrent ovarian cancer: An Italian study. ANTICANCER RESEARCH, 40(3), 1543-1550. Dettaglio

Futuri studenti - Iscrizioni